ACLS AXCELIS TECHNOLOGIES INC
Special Industry Machinery, NEC · Nasdaq · SEC CIK 1113232 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.3%
TTM net income YoY-23.1%
TTM EPS YoY-20.8%
Revenue 3-yr CAGR-6.4%
Net income 3-yr CAGR-23.4%
Margins
Gross margin42.8%
Operating margin10.3%
Net margin11.7%
FCF margin6.7%
EBITDA margin12.3%
Returns
ROE9.8%
ROA7.4%
ROIC (approx.)9.8%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets24.7%
Debt / equity0.00x
Current ratio4.43x
Interest coverage15.68x
Cash quality & payout
Operating cash flow / net income0.67x
Accruals ratio2.4%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $839.05M | $1.02B | $1.13B | $920.00M | $662.43M |
| Cost of revenue | $462.20M | $563.21M | $639.30M | $518.21M | $375.98M |
| Gross profit | $376.85M | $454.65M | $491.30M | $401.79M | $286.44M |
| R&D expense | $108.96M | $105.50M | $96.91M | $78.36M | $65.43M |
| SG&A expense | $83.21M | $70.32M | $65.79M | $57.47M | $46.14M |
| Operating income | $119.31M | $210.79M | $265.80M | $212.36M | $127.33M |
| Interest expense | $5.36M | $5.46M | $5.35M | $5.58M | $4.83M |
| Pretax income | $138.25M | $230.27M | $278.60M | $204.88M | $120.43M |
| Income tax | $18.01M | $29.28M | $32.34M | $21.81M | $21.78M |
| Net income | $120.24M | $200.99M | $246.26M | $183.08M | $98.65M |
| EBITDA | $136.93M | $226.60M | $278.86M | $223.97M | $138.14M |
| EPS (basic) | 3.81 | 6.17 | 7.52 | 5.54 | 2.94 |
| EPS (diluted) | 3.80 | 6.15 | 7.43 | 5.46 | 2.88 |
| Weighted avg. shares (diluted) | 31.67M | 32.70M | 33.16M | 33.54M | 34.27M |
| Banking | |||||
| Provision for credit losses | — | $3.45M | $1.12M | — | — |
| Balance sheet | |||||
| Cash & equivalents | $145.45M | $131.06M | $173.95M | $186.35M | $295.68M |
| Short-term investments | $228.80M | $447.83M | $338.85M | $246.57M | — |
| Receivables | $168.48M | $203.15M | $217.96M | $169.77M | $104.41M |
| Inventory | $329.01M | $282.23M | $306.48M | $242.41M | $194.98M |
| Current assets | $943.20M | $1.12B | $1.08B | $877.64M | $619.25M |
| PP&E, net | $56.15M | $53.78M | $53.97M | $39.66M | $34.97M |
| Total assets | $1.36B | $1.35B | $1.28B | $1.01B | $753.24M |
| Current liabilities | $197.66M | $207.52M | $285.13M | $248.13M | $150.14M |
| Total liabilities | $326.67M | $335.99M | $417.08M | $346.38M | $214.28M |
| Shareholders' equity | $1.03B | $1.01B | $864.88M | $667.26M | $538.96M |
| Shares outstanding | 30.72M | 32.37M | 32.69M | 32.77M | 33.24M |
| Cash flow statement | |||||
| Operating cash flow | $118.31M | $140.82M | $156.87M | $215.61M | $150.19M |
| Capital expenditure | $11.29M | $12.18M | $20.66M | $10.68M | $8.72M |
| Free cash flow | $107.01M | $128.64M | $136.21M | $204.92M | $141.47M |
| Investing cash flow | $29.93M | -$108.73M | -$100.86M | -$257.25M | -$8.72M |
| Financing cash flow | -$124.49M | -$71.19M | -$68.27M | -$65.48M | -$52.45M |
| Depreciation & amortization | $17.61M | $15.81M | $13.07M | $11.61M | $10.82M |
| Stock-based compensation | $20.77M | $20.95M | $18.27M | $13.44M | $12.07M |
| Share buybacks | $121.08M | $60.49M | $52.50M | $57.49M | $49.99M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.